Editor's Note

Transforming Pharmaceutical Innovation through Expert CDMO Partnerships

The pharmaceutical Contract Development and Manufacturing Organization (CDMO) industry is at a decisive turnpoint between scientific superiority and operational mastery, which is the basis that can make the difference between drug development and expansion of life-saving therapies reaching the patients across the globe in 2025. From complex biologics manufacturing and novel modality development to regulatory compliance and commercial-scale production, CDMOs are not merely executing contracts but are serving as strategic partners whose capabilities determine the success of breakthrough...  >>More